Your browser doesn't support javascript.
loading
Frequently asked questions (FAQs) about COVID-19 candidate vaccines and access mechanisms - version 2, 27 August 2020 / Preguntas frecuentes sobre las vacunas experimentales contra la COVID-19 y mecanismos de acceso - versión 2, 27 de agosto del 2020
Washington; Organización Panamericana de la Salud; Aug. 31, 2020.
Non-conventional in English, Spanish | LILACS | ID: biblio-1118286
RESUMEN
¿Existe una vacuna contra el SARS-CoV-2? ¿Tendrán éxito todas las vacunas experimentales contra la COVID-19? ¿Cuáles son las diferentes fases por las que una vacuna debe pasar para ser aprobada? Este documento responde a las preguntas más frecuentes sobre las vacunas experimentales y los mecanismos de acceso de los que disponen los países para acceder a la vacunación.
ABSTRACT
Is there a vaccine against COVID-19? Will all the COVID-19 candidate vaccines be successful? What are the different phases a vaccine must go through to be approved? This document provides responses to the most frequently asked questions about candidate vaccines and access to COVID-19 vaccination.
Subject(s)
Full text: Available Index: LILACS (Americas) Main subject: Pneumonia, Viral / Viral Vaccines / Clinical Trials as Topic / Coronavirus Infections / Pandemics / Betacoronavirus Limits: Humans Language: English / Spanish Year: 2020 Type: Non-conventional

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: LILACS (Americas) Main subject: Pneumonia, Viral / Viral Vaccines / Clinical Trials as Topic / Coronavirus Infections / Pandemics / Betacoronavirus Limits: Humans Language: English / Spanish Year: 2020 Type: Non-conventional